C07C 43/20
Having an ether-oxygen atom bound to a carbon atom of a six-membered
Official title: having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
C07C43/20 (Having an ether-oxygen atom bound to a carbon atom of a six-membered) appears on 2,268 US grants and 1,404 published applications in this corpus.
Search patents in C07C- Granted patents
- 2,268
- Published applications
- 1,404
- Assignees
- 1,001
- Inventors
- 5,008
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 20 | 0 |
| 1977 | 19 | 0 |
| 1978 | 22 | 0 |
| 1979 | 27 | 0 |
| 1980 | 29 | 0 |
| 1981 | 53 | 0 |
| 1982 | 47 | 0 |
| 1983 | 44 | 0 |
| 1984 | 39 | 0 |
| 1985 | 57 | 0 |
| 1986 | 49 | 0 |
| 1987 | 55 | 0 |
| 1988 | 46 | 0 |
| 1989 | 70 | 0 |
| 1990 | 57 | 0 |
| 1991 | 65 | 0 |
| 1992 | 69 | 0 |
| 1993 | 66 | 0 |
| 1994 | 59 | 0 |
| 1995 | 56 | 0 |
| 1996 | 60 | 0 |
| 1997 | 64 | 0 |
| 1998 | 57 | 0 |
| 1999 | 41 | 0 |
| 2000 | 43 | 0 |
| 2001 | 51 | 13 |
| 2002 | 33 | 33 |
| 2003 | 32 | 41 |
| 2004 | 24 | 65 |
| 2005 | 21 | 52 |
| 2006 | 29 | 44 |
| 2007 | 27 | 33 |
| 2008 | 25 | 48 |
| 2009 | 29 | 54 |
| 2010 | 31 | 60 |
| 2011 | 28 | 50 |
| 2012 | 33 | 38 |
| 2013 | 54 | 72 |
| 2014 | 44 | 63 |
| 2015 | 68 | 83 |
| 2016 | 66 | 96 |
| 2017 | 62 | 89 |
| 2018 | 67 | 60 |
| 2019 | 68 | 60 |
| 2020 | 56 | 60 |
| 2021 | 50 | 59 |
| 2022 | 27 | 52 |
| 2023 | 33 | 62 |
| 2024 | 35 | 47 |
| 2025 | 31 | 46 |
| 2026 | 30 | 24 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 43/23Containing hydroxy or o-metal groups1,180
- C07C 43/225Containing halogen848
- C07C 43/215Having unsaturation outside the six-membered aromatic rings398
- C07C 43/205The aromatic ring being a non-condensed ring324
- C07C 43/21Containing rings other than six-membered aromatic rings156
- C07C 43/202The aromatic ring being a naphthalene46
Recent patents
- Chlorinated fluoroaromatics and methods of using same6 Oct 2026US 12,753,140 B23M Innovative Properties Company
- Process for producing para-eugenol and/or ortho-eugenol15 Sep 2026US 12,735,378 B2Specialty Operations France
- Co-crystal of coenzyme QH and nicotinamide, preparation method therefor and use thereof25 Aug 2026US 12,715,832 B2Cocrystal Technology (Jiaxing) Co., Ltd.
- Lysis, binding and/or wash reagent for isolating and/or purifying nucleic acids30 Jun 2026US 12,668,790 B2Qiagen GmbH
- Compound for treating Alzheimer's disease16 Jun 2026US 12,655,088 B2East China University of Science and Technology
- Compound, composition, and package structure8 Oct 2026US 2026/0308096 A1Industrial Technology Research Institute
- Fluoroalcohols as co-solvents for chemical synthesis and methods for producing the same17 Sep 2026US 2026/0274774 A1The University of Mississippi
- Novel dimethylchalcone derivative3 Sep 2026US 2026/0257980 A1Chung Ang University Industry Academic Cooperation Foundation
- Use of cannabidiol derivative in preparation of medicament20 Aug 2026US 2026/0242320 A1Changchun Institute of Applied Chemistry Chinese Academy of Sciences
- Substituted Hydroxystilbene Compounds and Derivatives, Synthesis and Uses Thereof23 Jul 2026US 2026/0209152 A1Kynan Duke IP, LLC
Most cited
By later US patents
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995
- Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase198US 5,710,158 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1998
- C-aryl glucoside SGLT2 inhibitors and method184US 6,515,117 B2Bristol-Myers Squibb Company · 2003
- C-aryl glucoside SGLT2 inhibitors and method180US 6,414,126 B1Bristol-Myers Squibb Company · 2002